Recommended Principles of Antiretroviral Therapy in HIV Disease Scientific. Scientific Committee on AIDS and STI (SCAS) and Centre for Health Protection Department of Health Hong Kong (2011)

Recommended Principles of Antiretroviral Therapy in HIV Disease Scientific. Scientific Committee on AIDS and STI (SCAS) and Centre for Health Protection Department of Health Hong Kong (2011)

In 2005, the predecessor of this Committee, Scientific Committee on AIDS, published its set of recommended principles of antiretroviral therapy to provide general guidance for the use of antiretrovirals in Hong Kong. The document stated nine major principles of antiretroviral use.


Download this publication

Short-term Priorities for Antiretroviral Drug Optimization. WHO (2011)

who shortterm cover

The meeting was part of WHO’s commitment to the broader Treatment 2.0 initiative, coordinated by the UNAIDS Secretariat and WHO, which aims to radically simplify all aspects of quality HIV treatment, including drugs, diagnostics and healthcare delivery systems, to reduce costs and to mobilize communities towards greater engagement in programme design and implementation in resource-limited settings. Treatment 2.0 focuses on short– (1-3 years), medium– (4-6 years), and long– (7-10 years) term objectives to achieve and sustain universal access to treatment for all who need it and maximize the preventive benefits of treatment.


Download this publication

The Treatment 2.0 Framework for Action: Catalysing the Next Phase of Treatment, Care and Support. WHO and UNAIDS (2011)

who treatment cover

The document outlines how UNAIDS and WHO will work with partner organizations to accelerate global efforts to scale up treatment towards sustained universal access, optimizing both HIV specific and broader health outcomes, including maximizing the HIV and TB preventive benefits of ART. It reflects the need for innovation, for efficiency gains, for shifts in how programmes are financed and delivered, and for additional investments up front that will ultimately reduce costs in the medium and long-term.


Download this publication

HIV Testing and Treatment as Prevention in China. Wu Z (2011)

zun wu ppt

HIV Testing & Treatment as Prevention in China
National Center for AIDS/STD Control and Prevention
Chinese Center for Disease Control and Prevention


Download this publication

WHO Recommendations on the Management of Diarrhoea and Pneumonia in HIV-Infected Infants and Children: Integrated Management of Childhood Illness (IMCI). WHO (2010)

WHO Recommendations on the Management of Diarrhoea and Pneumonia in HIV-Infected Infants and Children: Integrated Management of Childhood Illness (IMCI). WHO (2010) The main causes of death among children under 5 years of age are acute respiratory infection (17%) and diarrhoeal disease (16%), and children infected with human immunodeficiency virus (HIV) have greater morbidity and mortality related to these conditions (WHO, 2008). An estimated 2.1 million children in the world are living with HIV, 90% of whom live in sub-Saharan Africa.

Download this publication

Treatment 2.0: Is This the Future of Treatment? UNAIDS (2010)

Treatment 2.0: Is This the Future of Treatment? UNAIDS (2010) The latest studies show that a reduction in new HIV infections of up to a third could be achieved globally if there is a radical overhaul of the way that the world provides antiretroviral therapy and if global leaders meet their commitments of ensuring that all people in need of treatment are on it.

Download this publication

Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infections in Infants Recommendations for a Public Health Approach 2010 Version. WHO (2010)

Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infections in Infants Recommendations for a Public Health Approach 2010 Version. WHO (2010) Significant progress is being made in the global scale-up of prevention of mother-to-child transmission of HIV (PMTCT), including in high burden and resource-limited settings. For the first time, the elimination of mother to-child transmission of HIV (MTCT) is now considered a realistic public health goal and an important part of the campaign to achieve the millennium development goals. In the light of the global effort, it is critically important to provide the best evidence-based interventions to reduce the risk of transmission from an HIV-infected mother to her newborn child, while at the same time promoting the health of both the mother and the child.

Download this publication

Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, 2010 Revision. WHO (2010)

Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, 2010 Revision. WHO (2010) Since the publication in 2006 of Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, new evidence has emerged on when to initiate ART, optimal ART regimens, the management of HIV coinfection with tuberculosis and chronic viral hepatitis and the management of ART failure. This evidence formed the basis for the recommendations contained in the 2010 update, which outlines a public health approach to the delivery of ART for adults and adolescents in settings with limited health systems capacity and resources. The recommendations were based on the preparation GRADE evidence profiles, systematic and targeted reviews, risk-benefit analyses, consultations with PLHIV, technical reports, and assessments of impact, feasibility and cost.

Download this publication

HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in HoChi Minh City. Trinh TT, Montague BT, Flanigan TP, et al (2010)

Five-Year Experience with Scaling-Up Access to Antiretroviral Treatment in an HIV Care Programme. Thai S, Koole O, Ros PU, et al (2009)

Vietnam is a country with one of the highest prevalences of HIV in Southeast Asia. With an estimated prevalence of 293 000 people in 2007 (approximately 0.5% of the general population), the HIV epidemic is primarily concentrated in urban areas among key high-risk populations, the majority of which are injection drug users (IDU)...


Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_Progress_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)